Eli Glezer

Founder at SINGULAR GENOMICS SYSTEMS, INC.

Net worth: 2 M $ as of 2024-04-29

55 year

Health Technology

Consumer Services

Profile

Dr. Eli Glezer is a Chief Scientific Officer at Singular Genomics Systems, Inc. Dr. Glezer was previously employed as a Chief Technology Officer by Meso Scale Diagnostics LLC.
He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from Harvard University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SINGULAR GENOMICS SYSTEMS, INC. 6.21%	2024-05-08	4,600,000 ( 6.21% )	2 M $	2024-04-29

Eli Glezer active positions

Companies	Position	Start
SINGULAR GENOMICS SYSTEMS, INC.	Founder	2016-05-31

All active positions of Eli Glezer

Former positions of Eli Glezer

Companies	Position	End
Meso Scale Diagnostics LLC Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD.	Chief Tech/Sci/R&D Officer	2015-12-31

See the detail of Eli Glezer's experience

Training of Eli Glezer

University of California, Berkeley	Undergraduate Degree
Harvard University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eli Glezer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SINGULAR GENOMICS SYSTEMS, INC.	Health Technology

Private companies	1
Meso Scale Diagnostics LLC Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Meso Scale Diagnostics LLC develops and markets solutions for multiplex biological assays. Its products include angiogenesis and vascular, bone metabolism, cytokine and chemokine, inflammation, intracellular signaling, neurodegeneration, toxicology, and immuno assay kits. The firms services include assay development, custom conjugation, prototype printing, instrument services and warranties. The company was founded in 1995 and is headquartered in Rockville, MD.	Health Technology